Cart
sales@molnova.com
Neuropeptide FF
CAS No. 99566-27-5
Neuropeptide FF( NPFF )
Catalog No. M29773 CAS No. 99566-27-5
Endogenous antiopioid peptide and agonist at NPFF1 and NPFF2 receptors (Ki values are 2.82 and 0.21 nM respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeuropeptide FF
-
NoteResearch use only, not for human use.
-
Brief DescriptionEndogenous antiopioid peptide and agonist at NPFF1 and NPFF2 receptors (Ki values are 2.82 and 0.21 nM respectively).
-
DescriptionEndogenous antiopioid peptide and agonist at NPFF1 and NPFF2 receptors (Ki values are 2.82 and 0.21 nM respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsNPFF
-
PathwayGPCR/G Protein
-
TargetNeuropeptide Y Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number99566-27-5
-
Formula Weight1081.27
-
Molecular FormulaC54H76N14O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (92.48 mM)
-
SMILES——
-
Chemical NameSequence:{Phe}{Leu}{Phe}{Gln}{Pro}{Gln}{Arg}{Phe}-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Mankus JV, et al. Nonpeptide ligands of neuropeptide FF: current status and structural insights. Future Med Chem. 2012 Jun;4(9):1085-92.
molnova catalog
related products
-
[cPP1-7,NPY19-23,Ala...
Potent, selective peptide agonist for the neuropeptide Y Y5 receptor (IC50 values for inhibition of NPY binding to human Y5, Y1, Y2 and Y4 receptors are 0.24, 530, > 500, and 51 nM respectively, Ki at Y5 = 0.1 - 0.15 nM). Stimulates food intake in vivo.
-
M617
Selective galanin GAL1 receptor agonist (Ki values are 0.23 and 5.71 nM for GAL1 and GAL2 receptors respectively). Enhances food consumption in rats following i.c.v. administration and reduces CAP-induced inflammatory pain.
-
Selvigaltin
Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.
